Company Filing History:
Years Active: 2020-2022
Title: Innovator Spotlight: Robert Zwolinski
Introduction
Robert Zwolinski, based in Napa, California, is a notable inventor with two patents under his name. His innovative contributions primarily focus on pharmaceutical devices, particularly in developing formulations that enhance patient care through improved drug delivery systems.
Latest Patents
Zwolinski's most recent patents revolve around preservative-free treprostinil devices. One of his patented inventions includes a sealed prefilled drug-reservoir that contains a unit dosage of treprostinil in a sterile fluid composition. This formulation ensures that the composition does not include an antimicrobial preservative, providing a safer and more efficient option for patients. The treprostinil concentration ranges between 0.1 mg/mL and 25 mg/mL. Furthermore, one of the formulations includes sodium chloride, enhancing the drug's effectiveness while ensuring patient safety by avoiding metacresol.
Another notable patent aims to create a unit dosage form of treprostinil for subcutaneous or intravenous injection. Similar to his previous invention, this formulation is designed to exclude antimicrobial preservatives which can cause irritation. The development of these methods is significant as it aims to reduce irritation and inflammation at the infusion site, greatly benefiting patients in need of this medication.
Career Highlights
Robert Zwolinski is currently employed at Steadymed Ltd., where his focus on drug delivery technology has contributed to advancing medical treatments. His expertise in developing sterile pharmaceutical compositions helps pave the way for innovations that prioritize patient comfort and safety.
Collaborations
Throughout his career, Zwolinski has collaborated with several talented individuals, including Jonathan Rigby and Peter Noymer. These collaborations have played a crucial role in the effective development of his patented inventions, allowing for a teamwork approach to tackling challenges in pharmaceutical innovations.
Conclusion
Robert Zwolinski's contributions to the field of pharmaceutical devices underscore the importance of innovation in improving patient care. Through his patents for preservative-free treprostinil devices, he continues to make a significant impact on patients' lives, pushing the boundaries of medical technology and ensuring safer, more effective treatment options.